PEDF Antibodies

Santa Cruz Biotechnology features a diverse variety of PEDF Antibodies for investigating Pigment Epithelium-Derived Factor (PEDF) in various biological processes. PEDF Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PEDF is a potent anti-angiogenic factor that plays a critical role in regulating cell survival, differentiation, and apoptosis. PEDF actively participates in neuroprotection and inhibits tumor growth, making it a significant focus in cancer research and therapeutic development. Research has shown that PEDF influences multiple signaling pathways involved in cell survival and growth. Understanding PEDF mechanisms can lead to breakthroughs in treating diseases characterized by abnormal angiogenesis. Investigating PEDF expression patterns helps reveal its role in different tissue types and developmental stages. Santa Cruz Biotechnology monoclonal antibodies for PEDF research support scientists worldwide in advancing our understanding of disease mechanisms and potential therapeutic approaches.